Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
James A. Graf currently holds 1,145,831 shares of NKGen Biotech, Inc. (NKGN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, James A. Graf has been a net buyer of NKGN stock. They have purchased $79.7K and sold $0 worth of shares.
James A. Graf's most recent insider trade was on Dec 20, 2024, when they sold 757,942 shares at $0.00 per share.
James A. Graf serves as Executive at NKGen Biotech, Inc. (NKGN). They have executed 54 insider transactions totaling $79.7K over their tenure at the company.
James A. Graf holds the position of Executive at NKGen Biotech, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 14 years and currently hold a stake valued at $0.
James A. Graf has shown a buying trading pattern, with $79.7K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by James A. Graf was on Sep 29, 2020, when they purchased $100.0K worth of VLDR shares. This transaction involved 10,000 shares at $10.00 per share.
James A. Graf currently owns 1,145,831 shares of NKGen Biotech, Inc. (NKGN), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of James A. Graf's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. James A. Graf has 54 Form 4 filings on record as an insider at NKGen Biotech, Inc..
Set alerts for James A. Graf and 40,000+ other insiders.